NOTE:  As provided in LFC policy, this report is intended only for use by the standing finance committees of the legislature.  The Legislative Finance Committee does not assume responsibility for the accuracy of the information in this report when used for other purposes.

 

The most recent FIR version (in HTML & Adobe PDF formats) is available on the Legislative Website.  The Adobe PDF version includes all attachments, whereas the HTML version does not.  Previously issued FIRs and attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.

 

 

F I S C A L   I M P A C T   R E P O R T

 

 

 

SPONSOR:

Lujan, B

 

DATE TYPED:

02/27/03

 

HB

939

 

SHORT TITLE:

Subcontractor Minimum Dispensing Fee

 

SB

 

 

 

ANALYST:

Weber

 

APPROPRIATION

 

Appropriation Contained

Estimated Additional Impact

Recurring

or Non-Rec

Fund

Affected

FY03

FY04

FY03

FY04

 

 

 

$0.0

 

 

 

 

 

 

 

 

 

 

(Parenthesis ( ) Indicate Expenditure Decreases)

 

SOURCES OF INFORMATION

 

Responses Received From

Human Services Department

Regulation and Licensing Department-Pharmacy Board

 

SUMMARY

 

     Synopsis of Bill

 

House Bill 939 (HB 939) seeks to amend the language in Section 27-2-16(B) which would allow sub-contractors of the Human Services Department (HSD) to negotiate an appropriate dispensing fee that is different from the minimum amount of $3.65 currently allowed in the law.

 

     Significant Issues

 

HB 939 would allow the Managed Care Organization (MCOs), and any other subcontractor for HSD, to negotiate appropriate dispensing fees based on rural or urban needs and difficult to serve populations, and may offers providers incentives to serve underserved areas and populations.

 

This would increase the flexibility of the contractors and HSD allowing for higher dispensing fees when necessary, and lower when appropriate.

 

This would eliminate HSD involvement in the ongoing Starko Lawsuit.

 

 

 

FISCAL IMPLICATIONS

 

Specific fiscal implications are indeterminate, but there be would impact on Medicaid pharmacy costs.

 

MW/ls